Don’t miss the Official launch of the NHMRC-funded program to eliminate hepatitis C in Australia!
Join community leaders, experts and policy makers to discuss current approaches and
challenges to the elimination of viral hepatitis.
Eliminating viral hepatitis in Australia is now possible with access to testing, treatment
and care, and a new, highly effective hepatitis B vaccine.
Hepatitis B and C affects more than 250,000 and 200,000 Australians, respectively, and are major contributors to deaths caused by liver cancer, liver failure and liver transplantation.
Globally, more than one million people die from viral hepatitis-related causes each year.
This year’s symposium will address local and global priorities, and build upon ground-breaking biomedical research, modelling and analysis that demonstrates the feasibility and public health benefit of eliminating viral hepatitis. There will be a particular focus on hepatitis C testing strategies and partnership approaches required to
Guest speakers will include Burnet Institute’s leading HCV researchers and clinicians,
collaborating partners, government, members of the community and affected populations.
Opening and Closing Address:
- Associate Professor Heidi Drummer, Burnet Institute
Professor Alex Thompson, St Vincent’s Hospital
Dr Alisa Pedrana, Burnet Institute
Associate Professor Ben Cowie, Doherty Institute
Mr Chad Hughes, Burnet Institute
Mr Charles Henderson, Harm Reduction Victoria
Dr Fran Bramwell, Healthworks
Mr Huy Van, Burnet Institute
Dr Jacqui Richmond, Eliminate Hep C Partnership
Dr Bridget Williams, Burnet Institute
Dr Joseph Doyle, Burnet Institute, The Alfred hospital and Monash University
Professor Margaret Hellard, Burnet Institute
Ms Melanie Eagle, Hepatitis Victoria
Dr Peter Higgs, La Trobe University and Burnet Institute
FREE event. Registration essential.